Commerzbank Aktiengesellschaft’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-614
Closed -$1.16M 973
2018
Q3
$1.16M Hold
614
0.01% 537
2018
Q2
$1.25M Sell
614
-12
-2% -$27.4K 0.01% 494
2018
Q1
$1.38M Sell
626
-10
-2% -$25.4K 0.01% 482
2017
Q4
$1.47M Sell
636
-106
-14% -$215K 0.02% 453
2017
Q3
$1.32M Buy
742
+312
+73% +$436K 0.02% 423
2017
Q2
$585K Sell
430
-70
-14% -$84.5K 0.01% 494
2017
Q1
$588K Buy
+500
New +$510K 0.01% 598

Other funds holding BLUE

Commerzbank Aktiengesellschaft's BLUE Position: Q4 2018 in Review

Commerzbank Aktiengesellschaft sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 614 shares — an estimated $1.16M sold.

Commerzbank Aktiengesellschaft first reported a position in BLUE in Q1 2017 and held it in 7 quarters. The position peaked at $1.47M in Q4 2017. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

  • Commerzbank Aktiengesellschaft reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 614 bluebird bio shares in Q4 2018, an estimated $1.16M.
  • Commerzbank Aktiengesellschaft first reported a position in bluebird bio in Q1 2017 and held it in 7 quarters.
  • Commerzbank Aktiengesellschaft's bluebird bio position peaked at $1.47M in Q4 2017.
  • 251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2018, filed 6 Feb 2019.